Medindia

X

Data Presented at Two Global Medical Congresses Reinforce Benefit of EnbrelŪ (etanercept) for Patients with Chronic Inflammatory Conditions

Wednesday, May 25, 2011 General News J E 4
Advertisement
New Interim Results from the PRESERVE Study Evaluate ENBREL Therapy in Patients with Moderately Active Rheumatoid Arthritis

CONTACT:

Amgen

Pfizer

Christine Regan (media)

Victoria Davis (media)

Office: 805-447-5476

Office: 212-733-3227

Cell: 617-359-1324

Cell: 347-558-3455

Arvind Sood (investors)

Jennifer M. Davis (investors)

Office: 805-447-1060

Office: 212-733-0717

Carrie Deverell, +41 41 3690 308 (European media)

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Shake Weight Gets Serious
S
Planet Fitness Sale Raises Over $370,000 for The B...